Webster Bank N. A. boosted its stake in shares of MetLife, Inc. (NYSE:MET – Free Report) by 21.3% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,138 shares of the financial services provider’s stock after buying an additional 200 shares during the quarter. Webster Bank N. A.’s holdings in MetLife were worth $93,000 as of its most recent SEC filing.
Other institutional investors also recently added to or reduced their stakes in the company. MeadowBrook Investment Advisors LLC boosted its position in MetLife by 244.4% during the third quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 220 shares during the period. Carmichael Hill & Associates Inc. boosted its position in MetLife by 131.9% during the third quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock worth $27,000 after purchasing an additional 186 shares during the period. Wolff Wiese Magana LLC boosted its position in MetLife by 374.3% during the third quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock worth $29,000 after purchasing an additional 277 shares during the period. Peterson Financial Group Inc. bought a new position in MetLife during the third quarter worth about $30,000. Finally, Retirement Wealth Solutions LLC bought a new position in MetLife during the fourth quarter worth about $32,000. Institutional investors own 94.99% of the company’s stock.
Wall Street Analyst Weigh In
A number of equities analysts have weighed in on the stock. JPMorgan Chase & Co. increased their target price on shares of MetLife from $86.00 to $88.00 and gave the stock an “overweight” rating in a research report on Tuesday, January 7th. Piper Sandler increased their price target on shares of MetLife from $85.00 to $92.00 and gave the stock an “overweight” rating in a report on Wednesday, October 2nd. StockNews.com downgraded shares of MetLife from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. BMO Capital Markets assumed coverage on shares of MetLife in a report on Thursday, January 23rd. They issued a “market perform” rating and a $97.00 price target on the stock. Finally, TD Cowen increased their price target on shares of MetLife from $97.00 to $99.00 and gave the stock a “buy” rating in a report on Wednesday, November 27th. Two investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $90.46.
MetLife Trading Up 1.1 %
Shares of MET opened at $86.97 on Tuesday. The firm’s 50 day simple moving average is $83.81 and its 200 day simple moving average is $80.11. The company has a market capitalization of $60.22 billion, a P/E ratio of 17.53, a P/E/G ratio of 0.65 and a beta of 1.07. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.16 and a quick ratio of 0.16. MetLife, Inc. has a 1-year low of $64.61 and a 1-year high of $89.05.
MetLife Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 11th. Shareholders of record on Tuesday, February 4th will be paid a dividend of $0.545 per share. This represents a $2.18 annualized dividend and a dividend yield of 2.51%. The ex-dividend date of this dividend is Tuesday, February 4th. MetLife’s dividend payout ratio (DPR) is presently 43.95%.
MetLife Company Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Stories
- Five stocks we like better than MetLife
- Overbought Stocks Explained: Should You Trade Them?
- Sizing Up a New Opportunity for NVIDIA Investors
- Learn Technical Analysis Skills to Master the Stock Market
- Is DeepSeek Challenging NVIDIA’s AI Dominance?
- Business Services Stocks Investing
- The 3 Biggest M&A Stock Opportunities for 2025
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.